Alloproteins, proteins which contain unnatural amino acids, have immense potential in biotechnology and medicine. Although various approaches for alloprotein production exist, there is no satisfactory method to produce large quantities of alloproteins containing unnatural amino acids in specific positions. The tyrosine analogue azatyrosine, L-β-(5-hydroxy-2-pyridyl)-alanine, can convert the ras-transformed phenotype to normal, presumably by its incorporation into cellular proteins. This provided the stimulus for isolation of a mutant tyrosyl-tRNA synthetase (TyrRS) capable of charging azatyrosine to tRNA. A plasmid library of randomly mutated E. coli tyrS (encoding TyrRS) was made by PCR techniques. The desired TyrRS mutants were selected by screening for in vivo azatyrosine incorporation of E. coli cells transformed with the mutant tyrS plasmids. One of the clones thus isolated, R-6-A-7, showed a 17-fold higher in vivo activity for azatyrosine incorporation than wild-type TyrRS. The mutant tyrS gene contained a single point mutation resulting in replacement of phenylalanine by serine at position 130 in the protein. Structural modeling revealed that position 130 is located close to Asp182 which directly interacts with tyrosyladenylate. Kinetic analysis of aminoacyl-tRNA formation by wild-type and the mutated F130S TyrRS enzymes showed that the specificity for azatyrosine, measured by the ratios of kcat/Km for tyrosine and the analog, increased from 17 to 36 as a result of the F130S mutation. Thus, the high discrimination against azatyrosine is significantly reduced in the mutant enzyme. These results suggest that utilization of F130S TyrRS for in vivo protein biosynthesis may lead to efficient production of azatyrosine-containing alloproteins.
Introduction
We previously reported that the tyrosine analogue azatyrosine, (L-β-(5-hydroxy-2-pyridyl)-alanine), has the unique property of converting c-Ha-ras, c-raf or c-erbB-2 transformed NIH3T3 cells to apparently normal phenotype, when it is added to the tissue culture medium (1) . The same phenomenon was also observed with the human pancreatic cancer cell line, PSN-1; these cells have an activated c-Ki-ras mutation (G12R), a p53 mutation and c-myc amplification (1) . However, NIH3T3 cells transformed by hst or src were not converted to the normal phenotype on treatment with azatyrosine (1) . When c-erbB-2 transformed NIH3T3 cells were treated with azatyrosine, phosphorylation of c-Raf and c-Jun were inhibited, while the amount of GTP-bound Ras p21 and phosphorylation of c-ErbB-2 were not altered (2) . These results suggested that the azatyrosine effect is somewhere in the ras signal transduction pathway. Several indirect lines of evidence indicated that the effect of azatyrosine on conversion of the transformed phenotype to normal is due to its incorporation into cellular protein (3) . Radioactive azatyrosine was incorporated into a small amount of cellular protein, and the amount of azatyrosine incorporated decreased upon addition of tyrosine to the tissue culture medium, concomitant with the inability to convert the transformed phenotype to normal (3) .
The concentration of azatyrosine needed for phenotype conversion was quite high (250-500 µg/ml) (1-3).
This hampered the further study of the crucial protein(s) involved in phenotype conversion by azatyrosine incorporation. Previously we showed that a chemically synthesized EGF fragment containing azatyrosine in place of tyrosine is not efficiently phosphorylated by EGF receptor kinase (4) . It is tempting to speculate that the activity of a protein important in the ras signal transduction pathway is affected by having azatyrosine instead of tyrosine. To aid further analysis of azatyrosine function a mutant tyrosyl-tRNA synthetase (TyrRS) 1 Substrates -Azatyrosine, L-β-(5-hydroxy-2-pyridyl)-alanine, was prepared in our institute from the culture broth of Streptomyces sp. SE-1346 (FERM BC-1536) by the method of Inoue et al. (9) . The purity of this azatyrosine preparation was shown to be more than 99.9% by high performance liquid chromatography.
L-[Methylene-3 H]-azatyrosine was obtained from Amersham (UK).
Random Mutagenesis of tyrS -Two oligonucleotides were synthesized. Primer 1 (5'-ATGGCAAGCAGTAACTTGA-3') was located near the 5' end of the TyrRS gene (8) . Primer 2 (5'-GAATACTCATACTCTTCCT-3') was located in the pBR322 gene near the SspI cloning site. E. coli tyrS was amplified and mutagenized by a modified PCR method using the synthesized primers as described by Leung et al. (10) . The PCR products were digested with MunI, 25 bp from the 5'-end of the TyrRS gene and SspI, and inserted into pYRS instead of the wt TyrRS gene at the SspI/MunI site to generate a mutant library. 
Screening Mutant tyrS clones -

Purification of E. coli wt and F130S TyrRS -JM109/pQE-YRS or JM109/pQE-F130S were cultured in
2 L of LB medium at 37ºC and harvested when A600 reached 0.8. The expression of histidine-tag fused wt TyrRS (His-wt TyrRS) or thistidine-tag fused F130S (His-F130S) was induced by the addition of isopropyl-β-D-thiogalactopyranoside (IPTG) at a final concentration of 1 mM, followed by incubation with vigorous shaking at 37ºC for 3.5 h. The cells were harvested by centrifugation at 6,000 g for 15 min. The cell pellets were washed twice with 0.85 % NaCl. The cell pellets were then resuspended in buffer A (50 mM potassium phosphate (pH 7.0), 300 mM NaCl, 0.1 mM phenylmethylsulfonyl fluoride and 10 % glycerol) and lysed by sonication. PEG8000 was added to the lysates at a final concentration of 7.5% and the lysates were centrifuged at 30,000 g for 20 min. The supernatants were applied to a Ni-NTA column (QIAGEN), and proteins were fractionated using a 0-500 mM imidazole gradient in buffer A. Fractions containing His-wt TyrRS or His-F130S were pooled and dialyzed against 50 mM potassium phosphate (pH7.0), 10 mM 2-mercaptoethanol, 0.1 mM PMSF and 50 % glycerol. TCA. The disks were then washed with 10 % TCA, and radioactivity was measured by scintillation counting.
The initial rate was determined at various tyrosine or azatyrosine concentrations from the time course. Kinetic parameters were obtained from Lineweaver-Burk plots according to the procedures as described previously (11, 12) . The values of Km and kcat of E. coli wt TyrRS for tyrosine were in good agreement with those previously published by Buorocore et al (13) . 
Fractionation of E. coli Proteins Labeled with Radioactive Tyrosine or
Results
Screening for mutant E. coli tyrS genes -For alloprotein synthesis in vivo we wanted to generate an E.
coli TyrRS mutant which can recognize azatyrosine efficiently. This is not an easy task, because with few exceptions (17,18) aminoacyl-tRNA synthetases recognize their natural counterpart more efficiently than unnatural amino acids (19) . At first we attempted a directed approach inspired by the Bacillus stearothermophilus TyrRS crystal structure (15) . We realized that the amino acid residues in the tyrosine binding site (YCGFD at positions 37 to 41) are conserved in E. coli TyrRS and reasoned that mutagenesis of these residues might be the best way of changing the substrate specificity of TyrRS. However, extensive cassette mutagenesis failed to generate any mutant TyrRS with the desired properties (unpublished results).
Possibly changes in these amino acids causes too much debilitation of amino acid recognition (20, 21 ).
Therefore we attempted random mutagenesis of the whole tyrS gene followed by large-scale screening. Errorprone, efficient PCR mutagenesis (10) was used. After re-cloning the mutant plasmid population was transformed into E. coli cells and the incorporation of radioactive azatyrosine was measured. The chromosomal wt tyrS copy in the E. coli transformants did not interfere in the assay as its gene product was much less (about 1%) expressed than the mutant genes on the plasmids (data not shown). Using this screening method, we selected one positive clone (R-6-A-7) among 1400 transformants analyzed. stearothermophilus TyrRS crystal structure (15) . This mutant was designated F130S and clone R-6-A-7 was renamed JM109/pF130S.
In Vivo Incorporation of Tyrosine or Azatyrosine by the E. coli R-6-A-7 Plasmid -
The mutant TyrRS is temperature-sensitive. Preincubation of the pure enzyme at 50ºC for 10 min almost completely inactivated F130S, while this treatment did not affect wt TyrRS (data not shown). However, the enzyme was stable enough to be purified and analyzed. As the wt enzyme had the same specific activity either in unmodified or His-tagged form, we purified the His-tagged versions of the wt and F130S enzyme by Ni-NTA column chromatography and determined the Km and kcat values for tyrosine and azatyrosine ( Table 1 ). The
Km of F130S for tyrosine was almost 20-fold higher than that of wt TyrRS, showing that affinity of F130S to tyrosine was greatly reduced. On the other hand, the Km of F130S for azatyrosine was only increased 2-fold over that of wt TyrRS. The specificity against azatyrosine can be determined from the ratios of kcat/Km for the two amino acids: the specificity constant (22, 23) is 36 for wt TyrRS, while it is only 19 for the F130S mutant. Clearly, the mutant has a much reduced discrimination against azatyrosine. Combined with the fact that its Km for tyrosine is very much above physiological tyrosine levels (24), it is understandable why E. coli transformed with the F130S plasmid incorporates much azatyrosine into protein (Fig. 1) . Structure Modeling of E. coli TyrRS -To find out more of how the F130S substitution affects aminoacylation of azatyrosine and tyrosine, we examined the crystal structure of B. stearothermophilus TyrRS complexed with tyrosyl adenylate (15) . As there is a great sequence similarity (56% amino acid identity)
In vivo Incorporation of [ 3 H]-Azatyrosine into Cellular Protein -
between E. coli and B. strearothermophilus we felt that this would be meaningful. The mutation site (position 130) is located near the attachment site for tyrosyl adenylate (Fig. 3, a and b) ; amino acid 130 is close to D182 which directly interacts with the aminoacyl adenylate. Possibly the F130S replacement influences the conformation of the attachment site through its interaction with D182, thus affecting enzymatic specificity.
E. coli TyrRS and B. strearothermophilus TyrRS are homodimeric enzymes (24). Position 130 is also
relatively close to the dimer interface (Fig. 3, a) . As proper dimerization is crucial for correct amino acid binding, it is also possible that the F130S mutation might affect dimerization and subsequently the environment of the amino acid binding site (20,21).
Discussion
Aminoacyl-tRNA synthetase mutants with altered amino acid specificity would be of great interest. Very few studies on their generation have been reported (22, 23) ; they are certainly toxic in vivo due to the presence of misacylated tRNAs, which may be corrected or further altered by editing mechanisms (25) . A fine example of switching the amino acid specificity of human glutaminyl-tRNA synthetase to glutamate charging was based in inspired sequence/structure comparisons (23) . The amino acid specificity of B. stearothermophilus TyrRS was also modified by structure-based amono acid changes in the amino acid binding site (22) . We show here the generation of an E. coli TyrRS mutant that, compared to wt TyrRS, displays less discrimination against the tyrosine analogue azatyrosine. As TyrRS is not known to have an editing mechanism (27) this would provide the explanation of the increased azatyrosine incorporation into proteins observed in E. coli strains harboring the F130S tyrS gene (Fig. 1) . Ibba et al. (19) reported that mutation of A294 located in the amino acid binding site of E. coli phenylalanyl-tRNA synthetase resulted in acceptance of p-chlorophenylalanine, suggesting that change of the amino acid binding pocket size influences amino acid specificity. Contrary to this, the site of the mutation of our E. coli mutant TyrRS was found to be near the amino acid binding site; residue 130
interacts with D182 at the binding site (Fig. 3, a and b) . In addition, the models of wtl TyrRS with azatyrosyl adenylate, F130S TyrRS with tyrosyl adenylate, and that with azatyrosyl adenylate were constructed in the same manner as described (see Experimental Procedures). With these models, we calculated the binding energy of each substrate against each TyrRS. We found that mutant TyrRS with tyrosyl adenylate is energetically comparable with that with azatyrosyl adenylate, while normal TyrRS with tyrosyl adenylate was energetically more stable than that with azatyrosyl adenylate. 2 This result is consistent with the difference of Km of each substrate against each TyrRS. This energy calculation may be useful to identify which residues should be mutated to obtain mutant TyrRS enzymes with greater specificity for azatyrosyl adenylate.
An in vivo screen for isolation of a mutant aminoacyl-tRNA synthetase was reported recently by Liu and Schultz (28) . Since this method does not require radioactive amino acids, it may be useful for isolation of a 14 mutant aminoacyl-tRNA synthetase that can activate a large number of unnatural amino acids. As we focused only on one amino acid, we adopted a simple but rather laborious procedure in which incorporation of radioactive azatyrosine into protein was measured in vivo without previous selection. Clearly, a highthroughput screening procedure is desirable for the isolation of more mutant TyrRS enzymes. In this regard it should be mentioned that growth of E. coli strains that harbor the pF130S plasmid is retarded by addition of azatyrosine to the culture medium (unpublished results).
The TyrRS:tRNA Tyr system differs from those of other aminoacyl-tRNA synthetases in the sense that prokaryotic tRNA Tyr possesses a unique structural feature distinct from that of eukaryotic tRNA Tyr (29) . Thus, TyrRS from prokaryotes and eukaryotes only recognizes cognate tRNA from the same species (5-7). This property of TyrRS may provide an excellent opportunity to produce azatyrosine-containing alloproteins.
Transfection of the E. coli F130S mutant tyrS gene (endowed with an appropriate promoter) together with the E. 
